Medication info
Telmisartan 80 mg (Telmisartan)

Telmisartan 80 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tablet
Manufacturer / importer
Myungmoon Pharmaceuticals Co., Ltd.
Appearance
White or almost white, double-convex round tablets
Packaging
30 tablets (10 tablets/PTP X 3), 100 tablets/bottle
Approval status
Active

MFDS item code 201804101 · Approved 2018.10.17 · Insurance code 649807350

Summary

Main use
Treatment of essential hypertension and prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily with water, with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. The maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment when the dose is increased. This drug has an additional blood pressure-lowering effect when administered in combination with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg of this drug orally once daily with water, with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this drug to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Myungmoon Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)

  • Essential hypertension
View approved original text

This medication is used for the treatment of essential hypertension, effectively lowering blood pressure and helping to reduce the risk of cardiovascular diseases. In particular, patients who cannot use ACE inhibitors, especially elderly individuals at high risk for cardiovascular diseases, may take this medication to reduce the risk of myocardial infarction, stroke, and death from cardiovascular diseases. It plays an important role in lowering the risk of major cardiovascular events related to hypertension.

How to take

Adult dose

1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily with water, with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. The maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment when the dose is increased. This drug has an additional blood pressure-lowering effect when administered in combination with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg of this drug orally once daily with water, with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this drug to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can cause serious harm to the fetus and newborn, especially during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Patients allergic to this medication or its components, pregnant or nursing women, patients with severe liver disorders or cholestasis, patients with hereditary angioedema, and those with diabetes or severe kidney impairment should not take this medication. Elderly patients, those with hyperkalemia, liver disorders, heart valve disease, ischemic heart disease, or cerebrovascular disorders should take this medication cautiously, as rapid decreases in blood pressure may increase the risk of myocardial infarction or stroke. Patients with a risk of ulcers or gastrointestinal bleeding should also be cautious while taking this medication, and special care is needed in patients with renal artery hypertension due to the risk of worsening kidney function. As this medication lowers blood pressure, symptoms such as hypotension, dizziness, or fainting may occur, as well as serious side effects such as hyperkalemia, kidney function abnormalities, liver dysfunction, and angioedema. If angioedema occurs, swelling of the face, lips, or throat and difficulty breathing may arise; discontinue use immediately and consult a healthcare professional. This medication may interact with other antihypertensives, diuretics, potassium supplements, lithium, and non-steroidal anti-inflammatory drugs (NSAIDs), so inform your doctor or pharmacist if you are taking any other medications. Pregnant women or those planning to become pregnant should avoid this medication, and nursing mothers are also advised to either avoid its use or discontinue breastfeeding. It is not recommended for children or those under 18 years of age, as its safety and efficacy have not been established. In case of overdose, symptoms such as hypotension, arrhythmias, dizziness, and acute renal failure may occur, requiring immediate medical treatment. While taking this medication, it is important to adhere to the prescribed dosage and regularly monitor blood pressure and conduct blood tests to check kidney function and electrolyte status. Dizziness or fainting may occur during driving or operating machinery, so caution is advised, and it should be stored out of reach of children.

Side effects

  • Upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 116 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • indigestion
  • abdominal bloating
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbances
  • liver function abnormalities
  • liver dysfunction
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • muscle pain
  • back pain
  • muscle cramps
  • joint pain
  • limb pain
  • tendon pain
  • acute kidney failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • increased liver enzymes
  • elevated serum creatine kinase
  • decreased hemoglobin
  • hypoglycemia
  • fatigue
  • hunger
  • cold sweats
  • tremors
  • decreased concentration
  • convulsions
  • altered consciousness
  • angioedema
  • laryngeal edema
  • severe hyperkalemia
  • kidney failure
  • shock
  • loss of consciousness
  • liver dysfunction
  • jaundice
  • dyspnea
  • hypotension
  • laryngeal edema
  • interstitial pneumonia
  • fever
  • abnormal chest X-ray
  • rhabdomyolysis
  • muscle pain
  • elevated creatine kinase
  • increased serum and urine myoglobin
  • palpitations
  • fatigue
  • nausea
  • insufficient efficacy
  • headache
  • dizziness
  • cough
  • indigestion
  • arrhythmia
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • loss of appetite
  • facial swelling
  • rash
  • hair loss
  • conjunctivitis
  • tinnitus
  • petechiae
  • headache
  • dizziness
  • muscle pain
  • dermatitis
  • dizziness
  • indigestion
  • cough
  • abdominal pain
  • loss of appetite
  • weakness
  • intestinal vascular edema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is best to maintain storage temperatures between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White or almost white, double-convex round tablets

Package unit

30 tablets (10 tablets/PTP X 3), 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.